Factors related to difficult self-expandable metallic stent placement for malignant colonic obstruction: A post-hoc analysis of a multicenter study across Japan.


Journal

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 07 02 2018
accepted: 12 08 2018
pubmed: 17 8 2018
medline: 8 5 2019
entrez: 17 8 2018
Statut: ppublish

Résumé

Colorectal cancer patients often present with large bowel obstruction. Elective placement of a self-expandable metallic stent (SEMS) can relieve obstruction, but can be challenging. Previous studies have compared cases by outcomes only, but the present study investigated successful cases only to identify factors related to prolonged and difficult SEMS placement in patients with malignant colonic obstruction. A post-hoc analysis of a multicenter clinical trial conducted between March 2012 and October 2013 at 46 facilities across Japan (UMIN000007953) was carried out; 511 patients who required SEMS placement for acute colorectal obstruction or symptomatic stricture secondary to malignant neoplasm were enrolled. Technical success rates and procedure times were recorded. Clinical and interventional parameters were investigated for their potential effect on procedure time by univariate and multivariate analyses. Technical success rate of SEMS placement was 98%. Median procedure time was 30 (range, 4-170) min. In 27% of patients, procedure time exceeded 45 min, indicating technically difficult placement. Multivariate analyses showed significant associations between technically difficult placement and a ColoRectal Obstruction Scoring System (CROSS) score of 0 before SEMS placement (odds ratio [OR], 1.6; P < 0.05), tumor site in the right colon (OR, 2.5; P < 0.0001), stricture length ≥5 cm (OR, 2.2; P < 0.001), peritoneal carcinomatosis (OR, 1.7; P < 0.05), and multiple SEMS placement (OR, 8.0; P < 0.01). Clinicians must anticipate technical challenges in cases with peritoneal carcinomatosis, a CROSS score of 0, or expansive strictures; such cases require experienced clinicians to carry out SEMS placement.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Colorectal cancer patients often present with large bowel obstruction. Elective placement of a self-expandable metallic stent (SEMS) can relieve obstruction, but can be challenging. Previous studies have compared cases by outcomes only, but the present study investigated successful cases only to identify factors related to prolonged and difficult SEMS placement in patients with malignant colonic obstruction.
METHODS METHODS
A post-hoc analysis of a multicenter clinical trial conducted between March 2012 and October 2013 at 46 facilities across Japan (UMIN000007953) was carried out; 511 patients who required SEMS placement for acute colorectal obstruction or symptomatic stricture secondary to malignant neoplasm were enrolled. Technical success rates and procedure times were recorded. Clinical and interventional parameters were investigated for their potential effect on procedure time by univariate and multivariate analyses.
RESULTS RESULTS
Technical success rate of SEMS placement was 98%. Median procedure time was 30 (range, 4-170) min. In 27% of patients, procedure time exceeded 45 min, indicating technically difficult placement. Multivariate analyses showed significant associations between technically difficult placement and a ColoRectal Obstruction Scoring System (CROSS) score of 0 before SEMS placement (odds ratio [OR], 1.6; P < 0.05), tumor site in the right colon (OR, 2.5; P < 0.0001), stricture length ≥5 cm (OR, 2.2; P < 0.001), peritoneal carcinomatosis (OR, 1.7; P < 0.05), and multiple SEMS placement (OR, 8.0; P < 0.01).
CONCLUSION CONCLUSIONS
Clinicians must anticipate technical challenges in cases with peritoneal carcinomatosis, a CROSS score of 0, or expansive strictures; such cases require experienced clinicians to carry out SEMS placement.

Identifiants

pubmed: 30113095
doi: 10.1111/den.13260
pmc: PMC7379649
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-58

Informations de copyright

© 2018 The Authors. Digestive Endoscopy published by John Wiley & Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.

Références

Gastrointest Endosc. 2018 Mar;87(3):705-713.e2
pubmed: 28579348
Asian J Surg. 2006 Jul;29(3):125-7
pubmed: 16877208
Surg Laparosc Endosc Percutan Tech. 2008 Aug;18(4):353-6
pubmed: 18716533
Can J Gastroenterol Hepatol. 2016;2016:1945172
pubmed: 27446826
J Gastrointest Surg. 2013 Nov;17(11):2007-12
pubmed: 24048614
JAMA Surg. 2013 Aug;148(8):715-22
pubmed: 23740130
Gastroenterology. 1993 Oct;105(4):988-98
pubmed: 8405884
Surg Oncol. 2004 Aug-Nov;13(2-3):149-57
pubmed: 15572097
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S44-9
pubmed: 14530657
J Pain Symptom Manage. 2014 Jul;48(1):75-91
pubmed: 24798105
Br J Surg. 2008 Aug;95(8):1012-9
pubmed: 18563787
Br J Surg. 2011 Feb;98(2):275-81
pubmed: 21082710
Br J Surg. 2002 Sep;89(9):1096-102
pubmed: 12190673
Dis Colon Rectum. 2007 Oct;50(10):1568-75
pubmed: 17687610
Surg Endosc. 2012 Nov;26(11):3106-13
pubmed: 22609981
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Am J Surg. 2011 Apr;201(4):456-62
pubmed: 21421099
Gastrointest Endosc. 2010 Mar;71(3):560-72
pubmed: 20189515
Colorectal Dis. 2005 May;7(3):251-3
pubmed: 15859963
Gastrointest Endosc. 2015 Oct;82(4):697-707.e1
pubmed: 25975529
World J Surg. 2015 Aug;39(8):2037-44
pubmed: 25894403
Br J Surg. 2004 May;91(5):605-9
pubmed: 15122613
Colorectal Dis. 2011 May;13(5):512-8
pubmed: 20128833
Gastrointest Endosc. 2011 Oct;74(4):858-68
pubmed: 21862005
Dis Colon Rectum. 1996 May;39(5):552-5
pubmed: 8620807
Surg Endosc. 2016 Sep;30(9):3976-86
pubmed: 26684205

Auteurs

Toshio Kuwai (T)

Department of Gastroenterology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Kure, Japan.

Toshiki Yamaguchi (T)

Department of Gastroenterology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Kure, Japan.

Hiroki Imagawa (H)

Department of Gastroenterology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Kure, Japan.

Shuntaro Yoshida (S)

Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hiroyuki Isayama (H)

Department of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Takeaki Matsuzawa (T)

Department of Digestive and General Surgery, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.

Tomonori Yamada (T)

Department of Gastroenterology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.

Shuji Saito (S)

Division of Surgery, Gastrointestinal Center, Yokohama Shin-Midori General Hospital, Yokohama, Japan.

Mamoru Shimada (M)

Department of Surgery, Toyonaka Midorigaoka Hospital, Toyonaka, Japan.

Nobuto Hirata (N)

Department of Gastroenterology, Kameda Medical Center, Kamogawa, Japan.

Takashi Sasaki (T)

Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation of Cancer Research, Tokyo, Japan.

Koichi Koizumi (K)

Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.

Iruru Maetani (I)

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University, Ohashi Medical Center, Tokyo, Japan.

Yoshihisa Saida (Y)

Department of Surgery, Toho University, Ohashi Medical Center, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH